March 17 (Reuters) - Health Canada:
* International clinical trials, including trials in Canada,
are being stopped due to serious adverse events with the drug
Zydelig, in combination with other cancer drugs
* Health Canada says three additional trials will be amended
by implementing added measures to protect participants
* Is also conducting a review of drug Zydelig and will take
appropriate next steps as needed
* Four Canadian clinical trials, involving cancer medicine
Zydelig (idelalisib) in combination with other cancer medicines,
being stopped
Source text for Eikon: ID:nCNWzmPVDa
Further company coverage: GILD.O